Heartflow Inc

HTFL

Market cap $2.82B

MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans.

MOUNTAIN VIEW, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members of management will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 13, 2026, at 1:30 p.m. PT / 4:30 p.m. ET.

Jeffrey Lightcap, a member of the Board of Directors of HeartFlow (HTFL 2.00%), acquired 40,000 common shares in an open-market transaction valued at $1,053,680 on Dec. 16, 2025; see SEC Form 4 filing.

The specialized healthcare diagnostics company earned two endorsements from heart health organizations. These concerned HeartFlow's plaque detection product.

Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment

Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health Service Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health Service

Tulsa-based Schusterman Interests added 1,939,201 shares of HeartFlow valued at $65.3 million in the third quarter. The position represents 14.9% of the fund's 13F reportable assets under management.

Added 12,448,158 shares in a new position, increasing reported holdings by $419.00 million Post-trade, the fund holds 12,448,158 shares worth $419.00 million The position now represents 27.81% of fund AUM, making it the fund's 1st-largest holding

MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Piper Sandler 37th Annual Healthcare Conference.

Acquired 312,234 shares of HeartFlow, estimated at ~$10.51 million based on quarterly average price Post-trade position: 312,234 shares, valued at $10.51 million as of 2025-09-30 New position places HeartFlow outside the fund's top five holdings by reported value